1. Home
  2. BDRX vs VERO Comparison

BDRX vs VERO Comparison

Compare BDRX & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDRX
  • VERO
  • Stock Information
  • Founded
  • BDRX 2000
  • VERO N/A
  • Country
  • BDRX United Kingdom
  • VERO Canada
  • Employees
  • BDRX N/A
  • VERO N/A
  • Industry
  • BDRX Biotechnology: Pharmaceutical Preparations
  • VERO Medical/Dental Instruments
  • Sector
  • BDRX Health Care
  • VERO Health Care
  • Exchange
  • BDRX Nasdaq
  • VERO Nasdaq
  • Market Cap
  • BDRX 5.8M
  • VERO 4.9M
  • IPO Year
  • BDRX N/A
  • VERO N/A
  • Fundamental
  • Price
  • BDRX $7.02
  • VERO $2.49
  • Analyst Decision
  • BDRX
  • VERO
  • Analyst Count
  • BDRX 0
  • VERO 0
  • Target Price
  • BDRX N/A
  • VERO N/A
  • AVG Volume (30 Days)
  • BDRX 147.7K
  • VERO 55.3K
  • Earning Date
  • BDRX 09-29-2025
  • VERO 08-14-2025
  • Dividend Yield
  • BDRX N/A
  • VERO N/A
  • EPS Growth
  • BDRX N/A
  • VERO N/A
  • EPS
  • BDRX N/A
  • VERO N/A
  • Revenue
  • BDRX N/A
  • VERO $60,997,000.00
  • Revenue This Year
  • BDRX N/A
  • VERO N/A
  • Revenue Next Year
  • BDRX N/A
  • VERO $7.47
  • P/E Ratio
  • BDRX N/A
  • VERO N/A
  • Revenue Growth
  • BDRX N/A
  • VERO N/A
  • 52 Week Low
  • BDRX $5.85
  • VERO $2.10
  • 52 Week High
  • BDRX $166.93
  • VERO $14.50
  • Technical
  • Relative Strength Index (RSI)
  • BDRX 31.98
  • VERO 48.22
  • Support Level
  • BDRX $5.85
  • VERO $2.41
  • Resistance Level
  • BDRX $8.75
  • VERO $2.77
  • Average True Range (ATR)
  • BDRX 0.62
  • VERO 0.15
  • MACD
  • BDRX -0.12
  • VERO -0.01
  • Stochastic Oscillator
  • BDRX 32.02
  • VERO 22.22

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

About VERO Venus Concept Inc.

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Share on Social Networks: